PDCD1 and colorectal carcinoma: Until now, the research in this field is mostly carried out at the tumor tissue level, whether methylation statuses of PDCD-1 and LAG-3 in PBL could be involved in the anomalous expression of ICs and related to CRC risk remain unclear.